Macular degeneration atrophic

There are no approved pharmacologic treatments for atrophic AMD. The Age-Related Eye Disease Study showed that a supplement containing ascorbic acid 500 mg, vitamin E 400 IU, beta carotene 15 mg, zinc oxide 80 mg, and cupric oxide 2 mg reduced the rate of clinical progression of all types of AMD by 28% in patients with at least intermediate macular degeneration. No benefit was seen in patients with earlier stages of age-related maculopathy however, the duration of the study may have been insufficient to detect this benefit.25... 

Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, and Nyland J (2004), Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration The Veterans LAST study (lutein antioxidant supplementation trial), Optometry 75 216-30. 

Richer, S, Devenport, J, and Lang, JC, 2007. LAST II Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Optometry 78, 213-219. 

---